These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9735866)

  • 1. Use of collagen for standardization of PBSC graft quality evaluation: a multicenter comparative analysis of commercial collagen-based and methylcellulose-based colony-forming unit (CFU) assay kits.
    Mossuz P; Dobo I; Genevay MC; Allegraud A; Dautel M; Niaussat AE; Cousin F; Praloran V; Boccaccio C; Hermouet S
    J Hematother; 1998 Aug; 7(4):351-9. PubMed ID: 9735866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducible scoring of CFU-GM and BFU-E grown in collagen-based semisolid medium after a short (3 h) training.
    Dobo I; Bidet JM; Acquart S; Allegraud A; Amiot L; Boccaccio C; Boiret N; Domenech J; Mossuz P; Sensebe L; Wunder E; Zandecki M; Hermouet S
    J Hematother; 1999 Feb; 8(1):45-51. PubMed ID: 10192301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CFU-Mk content of immunoselected CD34+ peripheral blood progenitor cells, evaluated with an adapted serum-free methylcellulose assay, is predictive of platelet lineage reconstitution in children with solid tumors.
    Boiret N; Kanold J; Fouassier M; Bons JM; Halle P; Rapatel C; Berger J; Pireyre P; Blanzat V; Travade P; Bonhomme J; Demeocq F; Berger MG
    J Hematother Stem Cell Res; 2000 Aug; 9(4):525-34. PubMed ID: 10982252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels.
    Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S
    J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspiration.
    Lefrère F; Hermine O; Audat F; Buzyn A; Cavazzana-Calvo M; Boccaccio C; Varet B
    Hematol Cell Ther; 1998 Jun; 40(3):133-7. PubMed ID: 9698222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of clonogenic progenitors in autologous peripheral blood stem cell grafts: evaluation of a simple in vitro assay suitable for routine clinical use.
    Motorin D; Bakken A; Foss Abrahamsen J; Ernst P; Bruserud Ø
    Hematology; 2003 Oct; 8(5):313-8. PubMed ID: 14530173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen matrix: an attractive alternative to agar and methylcellulose for the culture of hematopoietic progenitors in autologous transplantation products.
    Dobo I; Allegraud A; Navenot JM; Boasson M; Bidet JM; Praloran V
    J Hematother; 1995 Aug; 4(4):281-7. PubMed ID: 7489142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do two different stem cell grafts: G-CSF stimulated and unstimulated bone marrow differ according to hematopoietic colony forming capacity?
    Özgüner M; Azık MF; Tavil B; Bozkaya I; Köksal Y; Canal E; Uçkan D; Tunç B
    Transfus Apher Sci; 2014 Jun; 50(3):467-72. PubMed ID: 24656491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobilization of peripheral blood stem cells by subcutaneous injections of yeast-derived granulocyte macrophage colony stimulating factor: a phase I-II study.
    Mangan K; Mullaney M; Klumpp T; Goldberg S; Macdonald J
    Stem Cells; 1993 Sep; 11(5):445-54. PubMed ID: 8241955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of drug-induced hematotoxicity using novel in vitro monkey CFU-GM and BFU-E colony assays.
    Goto K; Goto M; Ando-Imaoka M; Kai K; Mori K
    J Toxicol Sci; 2017; 42(4):397-405. PubMed ID: 28717098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M.
    Bot FJ; van Eijk L; Schipper P; Löwenberg B
    Exp Hematol; 1989 Mar; 17(3):292-5. PubMed ID: 2645158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation.
    Mahmut N; Katayama Y; Takenaka K; Teshima T; Ohno Y; Imajyo K; Hara M; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M
    Int J Hematol; 1999 Jan; 69(1):36-42. PubMed ID: 10641441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.
    Goff JP; Shields DS; Boggs SS; Greenberger JS
    Radiat Res; 1997 Jan; 147(1):61-9. PubMed ID: 8989371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts.
    Kim DH; Jamal N; Saragosa R; Loach D; Wright J; Gupta V; Kuruvilla J; Lipton JH; Minden M; Messner HA
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1233-43. PubMed ID: 17889361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.